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Abstract Objective To investigate the needs of Dutch
general practitioners on discharge medication, both
regarding content, timing and the appreciation of pharma-
cotherapeutic advices from clinical pharmacists. Setting A
general teaching hospital in Amsterdam, the Netherlands.
Method A prospective observational study was performed.
A questionnaire with regard to the content, optimal timing
(including way of information transfer) and appreciation of
pharmacotherapeutic advices was posted to 464 general
practitioners. One reminder was sent. Main outcome mea-
sure Description of the needs of general practitioners was
assessed. For each question and categories of comments
frequency tables were made. The Fisher-exact test was
used to study associations between the answers to the
questions. Results In total, 149 general practitioners (32%)
responded. Most general practitioners (75%) experienced a
delay in receiving discharge medication information and
preferred to receive this on the day of discharge. GPs
wished to receive this information mainly through e-mail
(44%). There was a significant correlation (P = 0.002)
between general practitioners who wanted to know whether
and why medication had been stopped (87%) and changed
(88%) during hospital admission. The general practitioners
(88%) appreciated pharmacotherapeutic advices from
clinical pharmacists. Conclusion This study indicates how
information transfer on discharge medication to GPs can be
optimised in the Netherlands. The information arrives late
and GPs want to be informed on the day of discharge
mainly by e-mail. GPs wish to know why medication is
changed or discontinued and appreciate pharmacothera-
peutic advices from clinical pharmacists.
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Impact of findings on practice
• Dutch general practitioners want to be informed on
discharge medication on the day of discharge.
• Dutch general practitioners want information on rea-
sons for changes and discontinuations of the pharma-
cotherapy and appreciate pharmacotherapeutic advices
from clinical pharmacists.
• The exchange of information between hospital and
general practitioners needs to be optimized.
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Introduction
Patients are often discharged from the hospital on drug
therapy regimens different from those used before hospi-
talisation [1–3]. A recent study showed that in 98% of
patients the pharmacotherapy was changed in hospital and
in 60% of patients at least five changes were recorded [4].
These changes can be caused by for example alterations in
disease state or the need for increased drug efficacy [1].
Medical care in chronic illness is moving increasingly from
secondary to primary care [5]. The general practitioner
(GP), who is responsible for the patient after discharge,
must decide whether or not to maintain these changes,
often without valid information with respect to the reasons
for these changes [6].
At present information on medication is mainly
transferred through discharge letters, which arrive rela-
tively late and do not necessarily contain the information
the GP needs. Studies have shown the possible conse-
quences of inaccurate medication communication, for
example the inappropriate restart of medication, that has
been stopped during hospital admission due to adverse
drug reactions [7, 8]. In order to improve the information
transfer, policy documents outlining strategies to promote
medication safety for patients moving from one care
environment to another have been produced in the United
Kingdom, the United States and recently in the Nether-
lands [9–11]. Implementing recommended strategies for
safe medication transfer is likely to be more successful
when these strategies match with the information needs
of GPs. Limited (older) studies have focused on the
information needs of GPs regarding discharge medication
[1, 12–14]. However, the above mentioned policy docu-
ments [9–11] may have changed the need of GPs in
recent years.
Additionally, in the policy documents the need for
more cooperation between healthcare providers is dis-
cussed. In recent years clinical pharmacist have sup-
ported information transfer through checking for
medication errors, counselling of the patient at hospital
admission or discharge and provision of discharge med-
ication lists to GPs [12, 15]. Clinical pharmacists seek
for more collaboration with GPs as hospital physicians
do not always feel responsible for the complete phar-
macotherapy. However, it is unknown whether GPs
appreciate pharmacotherapeutic advices from clinical
pharmacists. Therefore, the aim of our study is to
investigate the needs of GPs on discharge medication,
both regarding content, timing (including way of infor-
mation transfer) and appreciation of pharmacotherapeutic
advices.
Method
Setting and study population
A prospective observational study was performed at the St.
Lucas Andreas Hospital in Amsterdam, the Netherlands, a
550-bed general teaching hospital. An anonymous ques-
tionnaire was posted to all GPs within the catchment area of
the hospital according to the hospital’s information system
(n = 464) in July 2007. GPs could reply by mail or fax. In
July and August questionnaires were received whereupon a
reminder was sent in September 2007, allowing a response
period of 2 months. The month of September was also
chosen for sending the reminder, to enable family physicians
to respond who were on holiday during the summertime.
This study was exempt from review by the institutional
review board, since the study concerned health care pro-
fessionals and did not involve any intervention. The data
were collected anonymously and stored in accordance with
privacy regulations.
Questionnaire and outcome
In our hospital, in general, a provisional discharge letter is
sent soon after hospitalization to inform the GP with a brief
summary. In this provisional discharge letter the discharge
medication should be mentioned. However, the discharge
letter contains the ward-specific medication and not the
complete list of medication the patient should be using.
Information on which medication is changed or discon-
tinued and reasons for this are generally not provided.
Therefore a questionnaire was designed to measure the
needs of GPs concerning discharge medication with regard
to the optimal timing, the optimal way of information
transfer, content of information and appreciation of phar-
macotherapeutic advices from clinical pharmacists.
Examples of pharmacotherapeutic advices are: adding
medication according to evidence-based guidelines (e.g.
statin for secondary prevention in a patient with type 2
diabetes), discontinuation of not indicated preadmission
used medication (e.g. iron tablets), monitoring compliance
of a patient, therapeutic drug monitoring, or monitoring of
electrolytes (e.g. potassium in patients using RAS-inhibi-
tors) and kidney (mal)function (e.g. digoxin).
The questionnaire contained seven closed and one open
question and was based on previous studies in primary care
[1, 13, 16]. Topics were: delay in receiving information,
the preferred time and way to receive this, requirement of
information about changes or discontinuations in the
pharmacotherapy, appreciation of pharmacotherapeutic
advices and suggestions to improve the communication
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transfer. The GP was invited to comment on each question.
The questionnaire was piloted on two persons. The revised
questionnaire was posted to the GPs.
Data analysis
Analysis was performed with SPSS 14.0. For each question,
frequency tables were made. The content of the open ques-
tions was qualitatively analysed, and three to six exclusive
categories for each question were defined by FK and SDB.
Each answer was classified in one of these categories and
presented in frequency tables; differences in classification
were solved by discussion. To study potential associations
between the answers the Fisher-exact test was used.
Results
In total, 149 GPs (32%) responded to the questionnaire, of
whom 59 (12%) responded after the reminder. The results of
the questionnaire can be found in Table 1. Almost all GPs
(n = 143) added one or more additional remarks/suggestions
to the questions, which are described in detail in Table 2.
Timing of information
Most GPs (75%) experienced a delay in receiving information
about discharge medication and preferred to receive this on
the day of discharge (see Table 1). Of the GPs that com-
mented 55% stated that they were confronted with questions
of patients or family immediately after patient discharge and
26% wanted to arrange care activities after discharge. Twelve
percent of GPs considered medication information essential
to be responsible for the patient’s medication (see Table 2).
Some GPs (7%) remarked that information was not needed
instantly but could wait a few days as long as the patient was
well informed and it was easy to contact the hospital.
Content of information
The GPs wanted to know whether and why medication had
been stopped (87%) and changed (88%) during hospital
admission. In their comments they explained that this infor-
mation was important for educational purposes for themselves
(38%), to counsel the patient (29%) and to prevent medication
errors (14%). Furthermore, one GP used this information to
document any drug related problems in his computer system
to prevent re-prescription of an inappropriate drug.
Pharmacotherapeutic advices
Most GPs (88%) appreciated pharmacotherapeutic advices
by clinical pharmacists concerning possible improvements
on discharge medication. They remarked (38%) that they
could learn from these advices. GPs (38%) further noticed
that the implementation of a pharmacotherapeutic advice in
individual patients should be a choice of the GP: there may
be good reasons for not following the advice. Twelve
percent of GPs did not want pharmacotherapeutic advices
at all. Two GPs commented that improvements in the
pharmacotherapy are the exclusive responsibility of the
GP.
Method of information transfer and additional
suggestions
GPs (75%) didn’t mind to receive the medication infor-
mation separate from the discharge letter as long as the
information was clear. The GPs (25%) that did mind
receiving a separate medication list commented that the GP
Table 1 GPs needs about the moment and content of information
about medication prescribed at discharge (n = 149)
Yes (%) No (%)
Moment of discharge medication information
Is there a delay in receiving information? 75 25
What is the preferred time to receive information?
Day of discharge 86
Within some days of discharge 7
Other 7
Content of information
Is information about changes in medication
during hospital admission necessary?
Yes, only what changes 9
Yes, both what changes and reasons for this 88
Not necessary 3
Is information about stopped medication during
hospital admission necessary?
Yes, only what stops 11
Yes, both what stops and reasons for this 87
Not necessary 2
Pharmacotherapeutic advices
Are pharmacotherapeutic advices from hospital
pharmacists about possible improvements
appreciated?
88 12
Method of information transfer
Is it a problem to receive discharge prescriptions
separate from the discharge letter?
25 75
What is the preferred way of information transfer?
(Discharge) letter 13
Fax 22
E-mail 44
Other 21
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should not have to search for the information. GPs wished
to receive information regarding medication mainly
through e-mail (44%).
In their open suggestions, 55 GPs noted some sugges-
tions for further improvements such as clear and complete
discharge medication communication, informing the
Table 2 Comments of GPs on
the questions (n = 143)
Questions Nr of comments (%)
What is the preferred time to receive information?
Day of discharge 42 (100%)
Patient or family have questions 23 (55%)
To arrange care activities 11 (26%)
GP is responsible for medication after discharge 5 (12%)
Other reasons 3 (7%)
Within some days after discharge 4 (100%)
Patient or family have questions 1 (25%)
To arrange care activities 1 (25%)
If GP has questions he can contact the hospital 1 (25%)
As long as patient has been well informed 1 (25%)
Other 3 (100%)
Both options are possible as long as patient has been well informed 2 (67%)
Depends on the patient (co-morbidities) 1 (23%)
Is information about changes and discontinued medication
during hospital admission necessary?
Yes, both what changes or stops and reasons for this 7 (100%)
GP could possibly learn from it 3 (43%)
To answer questions of patients 2 (29%)
To check whether the adjustment are intentional
to prevent re-prescription
2 (28%)
Are pharmacotherapeutic advices from hospital pharmacists about possible improvements appreciated?
Yes 8 (100%)
GP could possibly learn from it 3 (38%)
However implementation is a choice of GP 3 (38%)
However sometimes there are reasons for not prescribing a certain drug 2 (24%)
No 2 (100%)
Task and responsibility of GP
Is it a problem to receive discharge prescriptions separate from the discharge letter?
Yes 8 (100%)
Not advisable as GPs have to search for the information
No 14 (100%)
As long as the information is clear 5 (36%)
As long as GP receives information 5 (36%)
Other reasons 4 (28%)
Do you have further suggestions to improve the communication of medication information?
Yes 55 (100%)
Clear and complete information regarding discharge medication is
important (no handwritten forms, reason for changes provided etc.)
17 (31%)
Good initiative, further improvement is necessary 12 (22%)
Patient should also be informed with a medication list 7 (13%)
The right medication supply should be provided 5 (9%)
Substitution of medication in hospital should be prevented 5 (9%)
Consider cooperation with community pharmacy 2 (4%)
Other recommendations 7 (12%)
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patient about discharge medication, providing the right
medication supply to the patient, and substitution of med-
ication in the hospital to the medication used outside the
hospital.
Association between answers
There were no associations between the information
transfer being delayed and the preferred time to receive the
information, the information need about medication chan-
ges and discontinuations and the appreciation of pharma-
cotherapeutic advices (see Table 3). The wish to know
which medication was changed was significantly correlated
with the wish to know which medication was discontinued
(P = 0.002). This was not correlated with the appreciation
of pharmacotherapeutic advices.
Discussion
In our study 75% of GPs experienced a delay in receiving
information about discharge medication and 86% preferred
to receive this information on the day of discharge mainly
because they were confronted with questions of patients
and family immediately after patient discharge or wanted
to arrange care activities after discharge. GPs wished to
know why medication was changed (88%) or discontinued
(87%) for educational purposes for themselves, to counsel
the patient and to prevent medication errors. Most GPs
(88%) appreciated pharmacotherapeutic advices.
Changes in the pharmacotherapy during hospitalisation
may cause adverse drug reactions and/or drug interactions
at home [6]. Furthermore, reports have shown that many
changes in drug therapy on transfer of care are due to
medication errors [12, 13]. After being discharged from the
hospital, patients often contact their GP [16]. The late or
non-arrival of information and the failure to inform GPs
about changes in the pharmacotherapy could lead to the
continuation of medication errors in primary care [1, 2, 5,
6, 13, 17]. Studies reported that 77–96% GPs want to know
why medication is changed or discontinued, which is
consistent with the results in our study [1, 13]. Only
Munday et al. investigated in 1997 the reasons for these
findings and they documented the same reasons as in our
Table 3 Association between provided answers
Questions Association with delay in information transfer P value
Yes No
Preferred time to receive information 0.774
Day of discharge 92 (75.4%) 30 (24.6%)
Days later 13 (72.2%) 5 (27.8%)
Information need about medication changes 1.000
Changes (plus reasons) 102 (73.9%) 36 (26.1%)
Not important 5 (83.3%) 1 (16.7%)
Information need about medication discontinuations 1.000
Discontinuations (plus reasons) 103 (75.2%) 34 (24.8%)
Not important 2 (66.7%) 1 (33.3%)
Appreciation of pharmacotherapeutic advices 1.000
Yes 87 (74.4%) 30 (25.6%)
No 13 (76.5%) 4 (23.5%)
Discharge prescriptions separate from the discharge letter 0.504
Yes 27 (79.4%) 7 (20.6%)
No 75 (72.8%) 28 (27.2%)
Questions Association with information need about medication changes P value
Yes No
Information need about medication discontinuations 0.002
Discontinuations (plus reasons) 142 (98.6%) 2 (1.4%)
Not important 1 (33.3%) 2 (66.7%)
Appreciation of pharmacotherapeutic advices 0.512
Yes 121 (96.8%) 4 (3.2%)
No 18 (94.7%) 1 (5.3%)
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study, namely primarily to facilitate continuity of care, to
inform the patient, to avoid the risks of adverse drug
reactions, to eliminate prescribing errors and for educa-
tional purposes [1]. Himmel et al. showed that GPs
received detailed information about drug changes in only
five of the 130 hospital discharge letters showing the
necessity for improvement [6]. These problems may have
substantial implications for continuity of care and patient
safety [16, 18]. A recent study showed a trend toward a
decreased risk of readmission within 3 months if patients
were seen by a GP who had received a discharge letter
(relative risk, 0.74; 95% CI 0.05–1.10) [19].
Our study adds that the majority of GPs (88%) appre-
ciated pharmacotherapeutic advices by clinical pharmacists
concerning possible improvements in the discharge medi-
cation. This provides collaboration possibilities between
clinical pharmacist and general practitioners for example
in situations where the hospital physician does not feel
responsible for certain medication regimens (e.g. under-
treatment), extra monitoring of medication is needed (e.g.
kidney malfunction) or drug-related problems (e.g. com-
pliance, side-effects) are identified. A recent study showed
that GPs accepted advices and that these were well
received because the advices provided new information,
helped to better understand hospital recommendations and
influenced prescribing [20]. It is important to recognise
both the possible contribution of the clinical pharmacist to
give a clinically relevant advice to optimise pharmaco-
therapy, as the responsibility of the GP to fit this advice in
the individual drug therapy of the patient. Furthermore, the
role of the community pharmacist within this process needs
to be explored further.
There are several ways to inform GPs. In 1997 postal
communication was preferred [1]. As nowadays more GPs
have access to fax machines and electronic mail, these
communication methods are preferred in our population.
In this study it seems that not only GPs who experience
a delay in the information transfer wish to receive infor-
mation on the day of discharge, as no significant associa-
tion was identified between the answers to these questions.
Furthermore, the delay in information transfer was not
associated with the information need on medication chan-
ges, medication discontinuation and appreciation of phar-
macotherapeutic advices implicating that this information
was considered relevant anyway. The information need on
medication changes and medication discontinuation was
significantly correlated (P = 0.002) which is logical due to
the relation of the two information types. However the
information need on medication changes or discontinua-
tions was not correlated with the appreciation of pharma-
cotherapeutic advices which implicates that different
interventions can be developed to meet with the informa-
tion needs of GPs.
Although this is one of the few studies clearly showing
the informational needs of GPs, some limitations need to
be discussed. First, the results reflect the findings in one
geographical area, therefore limiting the generalizability of
the results, although the results are comparable to the few
other studies that have been conducted [1, 13, 16].
Second, the response rate was relatively low, even
though we sent a reminder. This may have led to selection
bias, because only the GPs with a more positive attitude
may have responded. Unfortunately, we were unable to
investigate this bias because of the anonymity of the
survey.
Notwithstanding these limitations, we believe that this
questionnaire provides important insight in the needs of
GPs concerning discharge medication.
Future studies should focus on implementing medication
transfer systems tailored to GPs information needs and on
the effect of implementing such systems on patient safety.
Medicine management teams who reconcile medication,
document changes and communicate this information to
GPs have been described in literature [2]. Furthermore,
future studies should also focus on how information
regarding discharge medication can be transferred using
standardized discharge letters. In the study of Van der
Linden et al. it did not matter whether an adverse drug
reaction was mentioned in the discharge letter or not for
prevention of re-prescription of inappropriate drugs [7].
This implies that GPs probably did not notice the infor-
mation on the adverse drug reaction. By designing future
studies using a before–after design and studying clinically
relevant endpoints (such as hospital readmissions), these
studies will be able to contribute to our knowledge on the
impact of implementing measures to improve the transfer
of discharge medication to GPs. The results of the survey
we have carried out, can aid in designing these measures
for improvement of discharge medication transfer. Future
interventions will reveal how sharing knowledge about
optimal pharmacotherapy by an advice of the clinical
pharmacist contributes to quality of pharmacotherapy.
Conclusion
This study indicates how information transfer on discharge
medication can be optimised in the Netherlands. It shows
that the information transfer to the GPs arrives late and that
they want to be informed on the day of discharge mainly by
e-mail. GPs wish to know why medication was changed or
discontinued and appreciate pharmacotherapeutic advices
from clinical pharmacists. For the further development of
discharge interventions, these findings can be useful to
design accurate discharge medication information sheets,
organise timely transfer of information, and give
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pharmacotherapeutic advices to streamline the communi-
cation process between hospital and general practitioner.
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